Stephens Consulting’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-20
Closed -$323 1914
2025
Q1
$323 Buy
+20
New +$323 ﹤0.01% 1439